LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="de Carvalho, Vinicius S"
  2. AU=Eisen Michael B
  3. AU="Manal S. Selim" AU="Manal S. Selim"
  4. AU="Alturki, Ramadan"
  5. AU="Kluger, Benzi"
  6. AU="Mitchell, Krista"
  7. AU="Oakes, Mary"
  8. AU="Kevill, Dennis N"
  9. AU="Rojas, Almudena"
  10. AU=Dalmau Josep AU=Dalmau Josep
  11. AU="Vaňáčová, Štěpánka"
  12. AU="Hancioglu, Baris"
  13. AU="Scribner, Kim T"
  14. AU="Emanuel Schmassmann"
  15. AU="Patel, Monica"
  16. AU=Passariello Margherita
  17. AU=Saikia Bedangshu
  18. AU="Dion, Dominique"
  19. AU="Magami, Shunsuke"
  20. AU="Wagner, Henrik"

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Defective hematopoietic differentiation of immune aplastic anemia patient-derived iPSCs.

    Tellechea, Maria Florencia / Donaires, Flávia S / de Carvalho, Vinícius S / Santana, Bárbara A / da Silva, Fernanda B / Tristão, Raissa S / Moreira, Lílian F / de Souza, Aline F / Armenteros, Yordanka M / Pereira, Lygia V / Calado, Rodrigo T

    Cell death & disease

    2022  Band 13, Heft 4, Seite(n) 412

    Abstract: In acquired immune aplastic anemia (AA), pathogenic cytotoxic Th1 cells are activated and expanded, driving an immune response against the hematopoietic stem and progenitor cells (HSPCs) that provokes cell depletion and causes bone marrow failure. ... ...

    Abstract In acquired immune aplastic anemia (AA), pathogenic cytotoxic Th1 cells are activated and expanded, driving an immune response against the hematopoietic stem and progenitor cells (HSPCs) that provokes cell depletion and causes bone marrow failure. However, additional HSPC defects may contribute to hematopoietic failure, reflecting on disease outcomes and response to immunosuppression. Here we derived induced pluripotent stem cells (iPSCs) from peripheral blood (PB) erythroblasts obtained from patients diagnosed with immune AA using non-integrating plasmids to model the disease. Erythroblasts were harvested after hematologic response to immunosuppression was achieved. Patients were screened for germline pathogenic variants in bone marrow failure-related genes and no variant was identified. Reprogramming was equally successful for erythroblasts collected from the three immune AA patients and the three healthy subjects. However, the hematopoietic differentiation potential of AA-iPSCs was significantly reduced both quantitatively and qualitatively as compared to healthy-iPSCs, reliably recapitulating disease: differentiation appeared to be more severely affected in cells from the two patients with partial response as compared to the one patient with complete response. Telomere elongation and the telomerase machinery were preserved during reprogramming and differentiation in all AA-iPSCs. Our results indicate that iPSCs are a reliable platform to model immune AA and recapitulate clinical phenotypes. We propose that the immune attack may cause specific epigenetic changes in the HSPCs that limit adequate proliferation and differentiation.
    Mesh-Begriff(e) Anemia, Aplastic/genetics ; Anemia, Aplastic/pathology ; Bone Marrow Failure Disorders ; Cell Differentiation ; Hematopoietic Stem Cells/pathology ; Humans ; Induced Pluripotent Stem Cells
    Sprache Englisch
    Erscheinungsdatum 2022-04-28
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2541626-1
    ISSN 2041-4889 ; 2041-4889
    ISSN (online) 2041-4889
    ISSN 2041-4889
    DOI 10.1038/s41419-022-04850-5
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemia.

    Catto, Luiz Fernando B / Zanelatto, Leonardo C / Donaires, Flavia S / de Carvalho, Vinicius S / Santana, Bárbara A / Pinto, André L / Fantacini, Daianne / de Souza, Lucas Eduardo B / Fonseca, Natasha P / Telho, Bruno S / Ayrosa Madeira, Maria Isabel / Barbosa Pagnano, Katia Borgia / Firmato, Ana Beatriz / Fagundes, Evandro Maranhão / Higashi, Marcia / Nunes, Elenaide Coutinho / Traina, Fabiola / Lobo de F Pontes, Lorena / Rego, Eduardo M /
    Calado, Rodrigo T

    Blood advances

    2023  Band 7, Heft 22, Seite(n) 7067–7078

    Abstract: TERRA (telomeric repeat-containing RNA) is a class of long noncoding RNAs transcribed from subtelomeric and telomeric regions. TERRA binds to the subtelomeric and telomeric DNA-forming R-loops (DNA-RNA hybrids), which are involved in telomere maintenance ...

    Abstract TERRA (telomeric repeat-containing RNA) is a class of long noncoding RNAs transcribed from subtelomeric and telomeric regions. TERRA binds to the subtelomeric and telomeric DNA-forming R-loops (DNA-RNA hybrids), which are involved in telomere maintenance and telomerase function, but the role of TERRA in human cells is not well characterized. Here, we comprehensively investigated for the first time TERRA expression in primary human hematopoietic cells from an exploratory cohort of patients with acute myeloid leukemia (AML), patients with acute lymphoblastic leukemia (ALL), patients with telomere biology disorder (TBD), and healthy subjects. TERRA expression was repressed in primary human hematopoietic cells, including healthy donors, patients with ALL, and patients with TBD, irrespective of their telomere length, except for AML. A second cohort comprising 88 patients with AML showed that TERRA was overexpressed in an AML subgroup also characterized by higher R-loop formation, low TERT and RNAseH2 expression, and a paucity of somatic splicing factor mutations. Telomere length did not correlate with TERRA expression levels. To assess the role of TERRA R-loops in AML, we induced R-loop depletion by increasing RNAseH1 expression in 2 AML cell lines. Decreased TERRA R-loops in AML cell lines resulted in increased chemosensitivity to cytarabine. Our findings indicate that TERRA is uniformly repressed in primary human hematopoietic cells but abnormally expressed in an AML subset with low telomerase.
    Mesh-Begriff(e) Humans ; Telomerase ; Leukemia, Myeloid, Acute/genetics ; Cell Line ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; RNA, Long Noncoding ; DNA
    Chemische Substanzen Telomerase (EC 2.7.7.49) ; RNA, Long Noncoding ; DNA (9007-49-2)
    Sprache Englisch
    Erscheinungsdatum 2023-09-29
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2023010658
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang